Lucy To
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Lucy To currently works at SAB Biotherapeutics, Inc., as Chief Financial Officer & Executive Vice President from 2024.
Ms. To also formerly worked at Wells Fargo & Co., as MD-Investment Banking Healthcare Group from 2020 to 2024.
Ms. To received her undergraduate degree from Southern Methodist University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Financieel Directeur/CFO | 12-08-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| WELLS FARGO & COMPANY | Corporate Officer/Principal | 01-06-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Wells Fargo & Co.
Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau